Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 VP-16-213 monotherapy for remission induction of small cell lung cancer: a randomized trial using three dosage schedules.

× No keyword cloud information.

43 in total

1. Etoposide in patients with previously untreated non-small-cell lung cancer: a phase I study.

Authors: N Niederle; J Ostermann; W Achterrath; L Lenaz; C G Schmidt
Journal: Cancer Chemother Pharmacol Date: 1991 Impact factor: 3.333

Review 2. Chemotherapy advances in small-cell lung cancer.

Authors: Bryan A Chan; Jermaine I G Coward
Journal: J Thorac Dis Date: 2013-10 Impact factor: 2.895

Review 3. Etoposide. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in combination chemotherapy of cancer.

Authors: J M Henwood; R N Brogden
Journal: Drugs Date: 1990-03 Impact factor: 9.546

4. Combination chemotherapy with cisplatin and etoposide associated with radiotherapy in the treatment of small-cell lung cancer.

Authors: F Figoli; A Veronesi; M G Trovo; D Errante; M Della Valentina; V Zagonel; R Talamini; M D Magri; S Monfardini
Journal: Cancer Chemother Pharmacol Date: 1989 Impact factor: 3.333

5. Treatment of small cell lung cancer with induction chemotherapy followed by late intensification.

Authors: P D Hardman; J A Green; R D Errington; S Myint; H M Warenius
Journal: Med Oncol Tumor Pharmacother Date: 1989

6. Extensive stage small cell carcinoma of the bronchus. A randomised study of etoposide given orally by one-day or five-day schedule together with intravenous adriamycin and cyclophosphamide.

Authors: G M Mead; J Thompson; J W Sweetenham; R B Buchanan; J M Whitehouse; C J Williams
Journal: Cancer Chemother Pharmacol Date: 1987 Impact factor: 3.333

VP-16-213 monotherapy for remission induction of small cell lung cancer: a randomized trial using three dosage schedules.

1. Etoposide in patients with previously untreated non-small-cell lung cancer: a phase I study.

Review 2. Chemotherapy advances in small-cell lung cancer.

Review 3. Etoposide. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in combination chemotherapy of cancer.

4. Combination chemotherapy with cisplatin and etoposide associated with radiotherapy in the treatment of small-cell lung cancer.

5. Treatment of small cell lung cancer with induction chemotherapy followed by late intensification.

6. Extensive stage small cell carcinoma of the bronchus. A randomised study of etoposide given orally by one-day or five-day schedule together with intravenous adriamycin and cyclophosphamide.

Review 7. The podophyllotoxin derivatives VP16-213 and VM26.

Review 8. Current development of podophyllotoxins.

Review 9. VP16-213 and podophyllotoxin. A study on the relationship between chemical structure and biological activity.

10. Evaluation of anticancer drug schedule dependency using an in vitro human tumor clonogenic assay.